$2.1M in expenses

Events held in a variety of global venues where members of the community are brought together to discuss advancements in organ transplantation. Organ transplantation is a successful therapy for end stage organ failure of the kidney, liver, heart, lung, pancreas and intestine. Transplantation of cells and tissues also transformed the therapeutic options for patients with malignant haematological disease, eye disease and orthopaedic disease, and has the potential to alter significantly the therapeutic options for patients with diabetes and a range of disorders. The access of patients to transplantation therapy varies widely across the globe, partly determined by the underlying level of economic development in different states and partly determined by other factors such as the availability of organ, cell and tissue donors, or the specialized provision of health services. The organization has determined that it will seek to address global inequities in transplantation therapy, in order to facilitate appropriate access to transplantation for all patients who would benefit.

$663K in expenses

Program and magazine publications including website development and webinars available to members only. These publications relate specifically to the field of organ transplantation.

$524K in expenses

AN INTERNATIONAL FORUM FOR THE WORLD-WIDE ADVANCEMENT OF ORGAN TRANSPLANTATION INCLUDING A FOCUS ON - DEVELOPMENT OF THE SCIENCE AND CLINICAL PRACTICE - SCIENTIFIC COMMUNICATION - CONTINUING EDUCATION - GUIDANCE ON THE ETHICAL PRACTICE OF TRANSPLANTATION. THE ORGANIZATION ACHIEVES THIS FOCUS BY MAKING GRANTS TO SECTION AND REGIONAL SOCIETIES FOR THE PURPOSE OF TRAVEL, RESEARCH FELLOWSHIP, AND RECOGNIZING INDIVIDUALS WHO HAVE MADE OUTSTANDING CONTRIBUTIONS IN TRANSPLANTATION. THE PRIMARY AWARDS AND GRANTS ARE: 1) THE MEDAWAR PRIZE, NAMED AFTER SOCIETY CO-FOUNDER SIR PETER MEDAWAR, IS RECOGNIZED AS THE WORLD'S HIGHEST DEDICATED AWARD FOR THE MOST OUTSTANDING CONTRIBUTIONS IN THE FIELD OF TRANSPLANTATION. THE MEDAWAR PRIZE HAS BEEN AWARDED TO TWO OR MORE RECIPIENTS AT EACH OF THE ORGANIZATION'S BIENNIAL CONGRESSES SINCE 1990. THE AWARD IS MADE POSSIBLE BY A GENEROUS GRANT FROM NOVARTIS PHARMA AG WHO AGREED THAT A PRESTIGIOUS PRIZE BE ESTABLISHED AND MAINTAINED TO RECOGNIZE THE OUTSTANDING INVESTIGATORS WHOSE CONTRIBUTIONS HAVE HAD SUCH A PROFOUND INFLUENCE ON THE FIELD OF ORGAN TRANSPLANTATION. 2) TTS Thomas Starzl Innovation Award. Named after Tom Starzl who was best known for his contributions to the field of organ transplantation, and often referred to as the "father of transplantation". The award recognizes individuals who, though advanced and original work, have contributed significantly to transplantation, thereby reflecting the spirit pioneered by Dr. Starzl. 3) TTS RESEARCH FELLOWSHIPS ARE OFFERED FOR A PERIOD OF 2 YEARS TO SUPPORT BASIC AND CLINICAL RESEARCH IN THE FIELD OF TRANSPLANTATION IN THE LABORATORY OR CLINICAL UNIT OF A FULL TTS MEMBER. THE FELLOWSHIPS ARE DESIGNED TO PROVIDE RESEARCH TRAINING FOR NEW YOUNG INVESTIGATORS WITH THE POTENTIAL OF MAKING A SIGNIFICANT CONTRIBUTION TO THE FIELD OF TRANSPLANTATION. 4) TRAVEL GRANTS FOR YOUNG INVESTIGATORS AND FOR THOSE WITH FINANCIAL DIFFICULTIES WHO ARE MEMBERS OF THE ORGANIZATION.

$48K in expenses

Other